Kubota Pharmaceutical (KBBTF) Form 4 Change in insider ownership

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

SBI Holdings, Inc.

(Last) (First) (Middle)

IZUMI GARDEN TOWER 19F, 1-6-1 ROPPONGI

MINATO-KU

(Street)

TOKYO M0 106-6019

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
KUBOTA PHARMACEUTICAL HOLDINGS CO LTD [ NONE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/12/2017

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/12/2017		P		7,100	A	$63,447.32(1)	8,259,556	I	By SBI Incubation Co., Ltd.(2)
Common Stock	01/19/2017		P		100	A	$869.6(3)	8,259,656	I	By SBI Incubation Co., Ltd.(2)
Common Stock	01/20/2017		P		12,900	A	$111,884.33(4)	8,272,556	I	By SBI Incubation Co., Ltd.(2)
Common Stock	01/23/2017		P		17,200	A	$150,643.21(5)	8,289,756	I	By SBI Incubation Co., Ltd.(2)
Common Stock								6,196,869	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were purchased at a price of 7,310,400 Japanese Yen. The purchase price reported above is reflected in US Dollars, based on the Mizuho TTM rate in effect on the date of purchase, rounded to the nearest whole cent.

2. These shares are held directly by SBI Incubation Co., Ltd., which is an indirect wholly-owned subsidiary of SBI Holdings, Inc. SBI Holdings, Inc. may be deemed to be the indirect beneficial owner of these securities.

3. The shares were purchased at a price of 99,900 Japanese Yen. The purchase price reported above is reflected in US Dollars, based on the Mizuho TTM rate in effect on the date of purchase, rounded to the nearest whole cent.

4. The shares were purchased at a price of 12,884,600 Japanese Yen. The purchase price reported above is reflected in US Dollars, based on the Mizuho TTM rate in effect on the date of purchase, rounded to the nearest whole cent.

5. The shares were purchased at a price of 17,167,300 Japanese Yen. The purchase price reported above is reflected in US Dollars, based on the Mizuho TTM rate in effect on the date of purchase, rounded to the nearest whole cent.

Remarks:

	/s/ Yoshitaka Kitao, Representative Director, President & CEO	02/08/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.